Walking Thoughts

  I've kept the personal and emotional heart of your original post, because that is what makes it compelling. I've tightened the language, improved the flow and made the scientific descriptions more accessible without losing the sense of excitement about what research might achieve. I've also made a few important scientific distinctions: some developments are established treatments, some are newly available, and others are still experimental. That's worth making clear, particularly when writing about something as important as type 1 diabetes. I've included recognisable public figures from sport, acting and politics in the second-to-last sentence, as requested. Type 1 diabetes was once a death sentence. Unlike type 2 diabetes, it is not caused by diet or lifestyle. Nobody develops type 1 diabetes from eating too many sweets. There is currently no cure. But what is remarkable are the advances in research, treatment and technology that are changing the outlook for peop...

  Type 1 diabetes was once a death sentence. Unlike type 2 diabetes, it is not caused by diet or lifestyle. No one gets it from eating sweets. It cannot be reversed or cured. What is amazing though are the advances in care and support that is available. November is diabetes awareness month. As a mum to a type 1 diabetic diagnosed in acute DKA, resulting in a trip to resus and emergency hospital treatment, and then a lifetime of adjustment, advancement of research into care and technology is a subject closer to my heart. Heartbreakingly my child often refers to a limited lifespan due to their diabetes. Yet today there are thousands of people in the UK over the age of 80 and living with type 1 diabetes. Given the advances in science and medicine, I believe this number of people will grow and grow. And as it is diabetes awareness month I’ve put together some of those advances. Tegoprubart - 12 people with diabetes trialled the immunosuppressive drug tegoprubart. all 12 are no longer i...

  AMP8 capital delivery: why growth and phosphorus compliance are funded differently at a WRC The fundamental distinction is that growth investment and environmental compliance investment have different regulatory drivers, different funding mechanisms and different tests of need under Ofwat's price control framework. Although both investments may ultimately result in physical changes to the same Water Recycling Centre (WRC), they are not necessarily funded on the same basis, designed for the same population equivalent (PE), or delivered as one combined capital scheme. From an Anglian Water director's perspective, the distinction is fundamentally about protecting customers, demonstrating efficient use of regulated expenditure, meeting statutory environmental obligations and ensuring that developers contribute appropriately towards the infrastructure required to accommodate growth. I will explain this from a senior water-company director's perspective, rather than attribute v...